Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) has provided an update.
Alembic Pharmaceuticals Limited’s Board of Directors has approved the unaudited consolidated and standalone financial results for the quarter and nine months ended 31 December 2025, along with the corresponding limited review reports from the statutory auditors. In the same meeting, the Board appointed Mr. Rajkumar Baheti as a Non-Executive Non-Independent Director, effective 1 April 2026 upon completion of his current tenure as Executive Director on 31 March 2026, subject to shareholder approval via postal ballot; the company also confirmed that he is not debarred by SEBI or any other authority from holding the office of director, indicating continuity and stability in its board-level leadership.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an Indian pharmaceutical company based in Vadodara, operating in the pharmaceuticals industry with a focus on manufacturing and marketing pharmaceutical products. The company is listed on both BSE and NSE, reflecting its position as a publicly traded player in the healthcare and drug manufacturing sector.
Average Trading Volume: 6,467
Technical Sentiment Signal: Sell
Current Market Cap: 157B INR
For an in-depth examination of APLLTD stock, go to TipRanks’ Overview page.